Switch to:
More From Other Websites
Theravance Biopharma Announces Health Canada Approval for VIBATIV(R) (telavancin) for Treatment of... Jul 23 2015
HTML PDF Jul 23 2015
Theravance to Report Second Quarter 2015 Financial Results on July 29, 2015 Jul 22 2015
THERAVANCE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 13 2015
Theravance, Inc. Appoints Michael Faerm as Chief Business Officer Jul 13 2015
HTML PDF Jul 02 2015
Theravance Biopharma Announces New Employment Inducement Awards Jul 02 2015
THERAVANCE INC Files SEC form 8-K, Regulation FD Disclosure Jul 01 2015
Theravance Biopharma Announces Marketing Authorization for VIBATIV(R) (Telavancin) in Russia for... Jun 30 2015
HTML PDF Jun 30 2015
HTML PDF Jun 26 2015
5 Biotech Stocks Poised for Breakouts Jun 05 2015
Theravance Biopharma Announces New Employment Inducement Awards Jun 02 2015
Theravance Biopharma and SciClone Pharmaceuticals Enter Into Development and Commercialization... May 27 2015
SciClone Pharmaceuticals and Theravance Biopharma Enter Into Development and Commercialization... May 27 2015
THERAVANCE INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits May 20 2015
Theravance Biopharma Presents Additional Positive Phase 2b Study Data on TD-4208 for Treatment of... May 20 2015
THERAVANCE INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits May 18 2015
Theravance Biopharma Presents Positive Phase 2 Study Data on Velusetrag (TD-5108) for Treatment of... May 18 2015
THERAVANCE INC Financials May 15 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK